With this extension, IXCHIQ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU). Saint ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory ...

1 Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ® - Valneva 2 Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension ...

Saint Herblain, France Tuesday, April 1, 2025, 16:00 Hrs [IST] ...

Valneva responds to French govt’s call for supply of chikungunya vaccine, Ixchiq: Saint Herblain, France Wednesday, March 26, 2025, 17:00 Hrs [IST] Valneva SE, a specialty vacci ...

SE announced earlier that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La ...

Valneva has been awarded funding ... The French biotech is the first company to bring a chikungunya vaccine to market, getting FDA approval for its Ixchiq (VLA1553) shot in November 2023 and ...

(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Valneva ... with IXCHIQ [Valneva's chikungunya virus ...

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ... vaccination with IXCHIQ [Valneva’s chikungunya virus vaccine ...

The authorities on the French overseas territory of Réunion Island have issued a health alert after more than 4,000 new cases ...

Valneva (NASDAQ ... Escherichia coli bacterium; IXCHIQ, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus; and VLA2001, an inactivated whole-virus ...